Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
Baxter
Harvard Business School
McKesson

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Ranbaxy Labs Ltd Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for RANBAXY LABS LTD, and what generic and branded alternatives to RANBAXY LABS LTD drugs are available?

RANBAXY LABS LTD has twenty-six approved drugs.

There are eight tentative approvals on RANBAXY LABS LTD drugs.

Summary for Ranbaxy Labs Ltd
US Patents:0
Tradenames:24
Ingredients:22
NDAs:26

Drugs and US Patents for Ranbaxy Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ranbaxy Labs Ltd DISPERMOX amoxicillin TABLET, FOR SUSPENSION;ORAL 065080-001 Aug 11, 2003 DISCN No No   Start Trial   Start Trial
Ranbaxy Labs Ltd FLUCONAZOLE fluconazole TABLET;ORAL 076386-004 Jul 29, 2004 DISCN No No   Start Trial   Start Trial
Ranbaxy Labs Ltd RANICLOR cefaclor TABLET, CHEWABLE;ORAL 065092-004 Dec 22, 2003 DISCN No No   Start Trial   Start Trial
Ranbaxy Labs Ltd SERTRALINE HYDROCHLORIDE sertraline hydrochloride CONCENTRATE;ORAL 078053-001 Feb 5, 2007 DISCN No No   Start Trial   Start Trial
Ranbaxy Labs Ltd LORATADINE loratadine SYRUP;ORAL 076529-001 Aug 20, 2004 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Dow
Merck
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.